328 related articles for article (PubMed ID: 18227707)
1. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
Chevalier J; Bonastre J; Avril MF
Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
[TBL] [Abstract][Full Text] [Related]
2. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
[TBL] [Abstract][Full Text] [Related]
3. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
4. The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs.
Reyes C; DaCosta Byfield S; Linke R; Satram-Hoang S; Teitelbaum AH
Melanoma Res; 2013 Apr; 23(2):159-66. PubMed ID: 23370422
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
[TBL] [Abstract][Full Text] [Related]
6. The economic costs of severe anaphylaxis in France: an inquiry carried out by the Allergy Vigilance Network.
Flabbee J; Petit N; Jay N; Guénard L; Codreanu F; Mazeyrat R; Kanny G; Moneret-Vautrin DA
Allergy; 2008 Mar; 63(3):360-5. PubMed ID: 18269678
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
[TBL] [Abstract][Full Text] [Related]
8. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
Ekwueme DU; Guy GP; Li C; Rim SH; Parelkar P; Chen SC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
[TBL] [Abstract][Full Text] [Related]
9. Inpatient management of patients with skin cancer in Germany: an analysis of the nationwide DRG-statistic 2005-2006.
Stang A; Stausberg J
Br J Dermatol; 2009 Nov; 161 Suppl 3():99-106. PubMed ID: 19775365
[TBL] [Abstract][Full Text] [Related]
10. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
11. [The cost of diabetes in metropolitan France].
Ricordeau P; Weill A; Vallier N; Bourrel R; Fender P; Allemand H
Diabetes Metab; 2000 Sep; 26 Suppl 6():25-38. PubMed ID: 11011237
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the medical activity related to cancer in a network of multidisciplinary hospitals using claims databases, the reseau Concorde Oncology Network].
Schott AM; Hajri T; Gelas-Dore B; Couris CM; Couray-Targe S; Trillet-Lenoir V; Dumeril B; Grandjean JP; Lledo G; Poncet JL; Colin C; Cautela N; Gilly FN
Bull Cancer; 2005 Feb; 92(2):169-78. PubMed ID: 15749646
[TBL] [Abstract][Full Text] [Related]
13. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France.
Horvais V; Touzet S; François S; Bourdy S; Bellon G; Colin C; Durieu I
Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688
[TBL] [Abstract][Full Text] [Related]
14. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
[TBL] [Abstract][Full Text] [Related]
15. [Macro-economic calculation of spending versus micro-economic follow-up of costs of breast cancer].
Borella L; Paraponaris A
Rev Epidemiol Sante Publique; 2002 Dec; 50(6):581-92. PubMed ID: 12515928
[TBL] [Abstract][Full Text] [Related]
16. [Economic burden of cancer in South Korea for the year 2005].
Kim J; Hahm MI; Park EC; Park JH; Park JH; Kim SE; Kim SG
J Prev Med Public Health; 2009 May; 42(3):190-8. PubMed ID: 19491563
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of hospital-treated Salmonella infection; data from a national cohort over a ten-year period.
Gil Prieto R; Alejandre CG; Meca AA; Barrera VH; de Miguel AG
J Infect; 2009 Mar; 58(3):175-81. PubMed ID: 19195712
[TBL] [Abstract][Full Text] [Related]
18. [The cost of chemotherapy].
Lévy C; Bonastre J
Bull Cancer; 2003 Nov; 90(11):976-82. PubMed ID: 14706901
[TBL] [Abstract][Full Text] [Related]
19. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data.
Kozak LJ; DeFrances CJ; Hall MJ
Vital Health Stat 13; 2006 Oct; (162):1-209. PubMed ID: 17091747
[TBL] [Abstract][Full Text] [Related]
20. Early intervention of negative pressure wound therapy using Vacuum-Assisted Closure in trauma patients: impact on hospital length of stay and cost.
Kaplan M; Daly D; Stemkowski S
Adv Skin Wound Care; 2009 Mar; 22(3):128-32. PubMed ID: 19247014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]